Diagnosis and management of pergolide-induced fibrosis.
Hirani
Naushad
N
Division of Respirology, University of Western Ontario, London, Canada.
Bayliff
Charles C
CC
Division of Respirology, University of Western Ontario, London, Canada.
McCormack
David G
DG
Division of Respirology, University of Western Ontario, London, Canada.
D000368:Aged; D001195:Asbestosis / Q000150:complications; D018491:Dopamine Agonists / Q000009:adverse effects*; D017809:Fatal Outcome; D006801:Humans; D008297:Male; D008654:Mesothelioma / Q000209:etiology; D010479:Pergolide / Q000009:adverse effects*; D010997:Pleural Neoplasms / Q000209:etiology; D011658:Pulmonary Fibrosis / Q000139:chemically induced*; D012148:Restless Legs Syndrome / Q000188:drug therapy*
D018491:Dopamine Agonists; D010479:Pergolide